Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 9590
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476230(US10874634, Cmpd No. 12 | US11364220, Compound 12)
Affinity DataIC50:  100nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476235(US10874634, Cmpd No. 17 | US11364220, Compound 17)
Affinity DataIC50:  290nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476224(US10874634, Cmpd No. 07 | US11364220, Compound 07)
Affinity DataIC50:  470nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476228(US10874634, Cmpd No. 10 | US11364220, Compound 10)
Affinity DataIC50:  550nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476237(US10874634, Cmpd No. 19 | US11364220, Compound 19)
Affinity DataIC50:  741nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476180(US10874634, Cmpd No. 02 | US11364220, Compound 02)
Affinity DataIC50:  830nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476217(US10874634, Cmpd No. 04 | US11364220, Compound 04)
Affinity DataIC50:  1.14E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476223(US10874634, Cmpd No. 06 | US11364220, Compound 06)
Affinity DataIC50:  1.29E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476234(US10874634, Cmpd No. 16 | US11364220, Compound 16)
Affinity DataIC50:  1.77E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476238(US10874634, Cmpd No. 21 | US11364220, Compound 21)
Affinity DataIC50:  1.90E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476180(US10874634, Cmpd No. 02 | US11364220, Compound 02)
Affinity DataIC50:  2.06E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476226(US10874634, Cmpd No. 09 | US11364220, Compound 09)
Affinity DataIC50:  2.20E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476225(US10874634, Cmpd No. 08 | US11364220, Compound 08)
Affinity DataIC50:  3.17E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476173(US10874634, Cmpd No. 01 | US11364220, Compound 01)
Affinity DataIC50:  5.66E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476231(US10874634, Cmpd No. 13 | US11364220, Compound 13)
Affinity DataIC50:  6.20E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476228(US10874634, Cmpd No. 10 | US11364220, Compound 10)
Affinity DataIC50:  8.23E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476221(US10874634, Cmpd No. 04B)
Affinity DataIC50:  8.24E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476173(US10874634, Cmpd No. 01 | US11364220, Compound 01)
Affinity DataIC50:  8.81E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476236(US10874634, Cmpd No. 18 | US11364220, Compound 18)
Affinity DataIC50:  9.07E+3nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476222(US10874634, Cmpd No. 05 | US11364220, Compound 05)
Affinity DataIC50:  1.15E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476234(US10874634, Cmpd No. 16 | US11364220, Compound 16)
Affinity DataIC50:  1.19E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476218(US10874634, Cmpd No. 04A)
Affinity DataIC50:  1.40E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476226(US10874634, Cmpd No. 09 | US11364220, Compound 09)
Affinity DataIC50:  1.42E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476217(US10874634, Cmpd No. 04 | US11364220, Compound 04)
Affinity DataIC50:  1.89E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476225(US10874634, Cmpd No. 08 | US11364220, Compound 08)
Affinity DataIC50:  1.92E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476229(US10874634, Cmpd No. 11)
Affinity DataIC50:  2.00E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476238(US10874634, Cmpd No. 21 | US11364220, Compound 21)
Affinity DataIC50:  2.18E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476232(US10874634, Cmpd No. 14 | US11364220, Compound 14)
Affinity DataIC50:  2.84E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476235(US10874634, Cmpd No. 17 | US11364220, Compound 17)
Affinity DataIC50:  3.87E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476222(US10874634, Cmpd No. 05 | US11364220, Compound 05)
Affinity DataIC50:  3.97E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476223(US10874634, Cmpd No. 06 | US11364220, Compound 06)
Affinity DataIC50:  4.23E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476181(US10874634, Cmpd No. 03 | US11364220, Compound 03)
Affinity DataIC50:  6.54E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476227(US10874634, Cmpd No. 09A | US11364220, Compound 09...)
Affinity DataIC50:  8.05E+4nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476233(US10874634, Cmpd No. 15 | US11364220, Compound 15)
Affinity DataIC50: >1.00E+5nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476237(US10874634, Cmpd No. 19 | US11364220, Compound 19)
Affinity DataIC50: >1.00E+5nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476181(US10874634, Cmpd No. 03 | US11364220, Compound 03)
Affinity DataIC50: >1.00E+5nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476232(US10874634, Cmpd No. 14 | US11364220, Compound 14)
Affinity DataIC50: >1.00E+5nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476231(US10874634, Cmpd No. 13 | US11364220, Compound 13)
Affinity DataIC50: >1.00E+5nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476229(US10874634, Cmpd No. 11)
Affinity DataIC50: >1.00E+6nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476224(US10874634, Cmpd No. 07 | US11364220, Compound 07)
Affinity DataIC50: >1.00E+6nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476233(US10874634, Cmpd No. 15 | US11364220, Compound 15)
Affinity DataIC50: >1.00E+6nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476230(US10874634, Cmpd No. 12 | US11364220, Compound 12)
Affinity DataIC50: >1.00E+6nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
Queens University At Kingston

US Patent
LigandPNGBDBM476236(US10874634, Cmpd No. 18 | US11364220, Compound 18)
Affinity DataIC50: >1.00E+6nMAssay Description:CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent